Assessment of coronary artery plaque with non-contrast and T1-weighted magnetic resonance: Promise for clinical use?

European Heart Journal

Volumn 40, Issue 41, 2019, Pages E20-E22

  Schindler, Thomas H ^a   Bax, Jeroen J ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORINE; EXENDIN 4; GADOLINIUM;

CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CAUSE OF DEATH; CLINICAL OUTCOME; CORONARY ANGIOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; DISEASE ASSOCIATION; DISEASE SEVERITY; HEART INFARCTION; HEART PERFUSION; HUMAN; INTRAVASCULAR ULTRASOUND; NON INVASIVE PROCEDURE; OPTICAL COHERENCE TOMOGRAPHY; PATIENT IDENTIFICATION; PERCUTANEOUS CORONARY INTERVENTION; PERSONALIZED MEDICINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SALVAGE THERAPY; X-RAY COMPUTED TOMOGRAPHY; ATHEROSCLEROTIC PLAQUE; CORONARY BLOOD VESSEL; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

CORONARY VESSELS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; PERCUTANEOUS CORONARY INTERVENTION; PLAQUE, ATHEROSCLEROTIC;

EID: 85074544718     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv246     Document Type: Review

References (15)

1. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 2014;35(42):2950-2959.
2. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2014;35(37):2541-2619.
3. Frohlich GM, Meier P, White SK, Yellon DM, Hausenloy DJ. Myocardial reperfusion injury: looking beyond primary PCI. Eur Heart J 2013;34(23):1714-1722.
4. Lansky AJ, Stone GW. Periprocedural myocardial infarction: prevalence, prognosis, and prevention. Circ Cardiovasc Interv 2010;3(6):602-610.
5. Niccoli G, Montone RA, Di Vito L, Gramegna M, Refaat H, Scalone G, Leone AM, Trani C, Burzotta F, Porto I, Aurigemma C, Prati F, Crea F. Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome. Eur Heart J 2015; doi:10.1093/eurheartj/ehv029.
6. Boogers MJ, Broersen A, van Velzen JE, de Graaf FR, El-Naggar HM, Kitslaar PH, Dijkstra J, Delgado V, Boersma E, de Roos A, Schuijf JD, Schalij MJ, Reiber JH, Bax JJ, Jukema JW. Automated quantification of coronary plaque with computed tomography: comparison with intravascular ultrasound using a dedicated registration algorithm for fusion-based quantification. Eur Heart J 2012;33(8):1007-1016.
7. Hoshi T, Sato A, Akiyama D, Hiraya D, Sakai S, Shindo M, Mori K, Minami M, Aonuma K. Coronary high-intensity plaque on T1-weighted magnetic resonance imaging and its association with myocardial injury after percutaneous coronary intervention. Eur Heart J 2015; doi:10.1093/eurheartj/ehv187
8. Babu GG, Walker JM, Yellon DM, Hausenloy DJ. Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection. Eur Heart J 2011;32(1):23-31.
9. Botker HE. Mitochondrial care in acute myocardial infarction. Eur Heart J 2015; 36(2):77-79.
10. Lonborg J, Vejlstrup N, Kelbaek H, Bøtker HE, Kim WY, Mathiasen AB, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Thuesen L, Krusell LR, Jensen JS, Køber L, Treiman M, Holst JJ, Engstrøm T. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur Heart J 2012; 33(12):1491-1499.
11. Schindler TH, Lima JA. Assessment of myocardial matrix expansion with cardiac magnetic resonance: entering a new area of cardiac risk stratification in type 2 diabetes mellitus? Eur Heart J 2014;35(10):608-611.
12. Wong TC, Piehler KM, Kang IA, Kadakkal A, Kellman P, Schwartzman DS, Mulukutla SR, Simon MA, Shroff SG, Kuller LH, Schelbert EB. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J 2014;35(10):657-664.
13. Selvanayagam JB, Porto I, Channon K, Petersen SE, Francis JM, Neubauer S, Banning AP. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation 2005;111(8):1027-1032.
14. Ehara S, Hasegawa T, Nakata S, Matsumoto K, Nishimura S, Iguchi T, Kataoka T, Yoshikawa J, Yoshiyama M. Hyperintense plaque identified by magnetic resonance imaging relates to intracoronary thrombus as detected by optical coherence tomography in patients with angina pectoris. Eur Heart J Cardiovasc Imaging 2012;13(5): 394-399.
15. Bhagirath P, van der Graaf M, Karim R, Rhode K, Piorkowski C, Razavi R, Schwitter J, Götte M. Interventional cardiac magnetic resonance imaging in electrophysiology: advances toward clinical translation. Circ Arrhythm Electrophysiol 2015;8(1): 203-211.